The human epidermal growth factor receptor-tyrosine kinase 2 (HER2) gene is amplified in 25–30% of breast cancers and this amplification causes overexpression of the encoded protein in 95% of cases (Slamon et al, 1987). Here, ERBB2 is linked to breast carcinoma.